Informed consent was not included in the published version of the following articles that appeared in previous issues of Leukemia Research Reports.
The appropriate informed consent statements, provided by the authors, are included below:
-
•
“Oral etoposide combined with oral arsenic plus retinoic acid for two cases with newly diagnosed high-risk acute promyelocytic leukemia during COVID19 pandemic” [Leukemia Research Reports, 2021; 16C: 100258] 10.1016/j.lrr.2021.100258
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Chronic myelogenous leukemia occurring in two brothers: The opposite sides of the same coin?” [Leukemia Research Reports, 2021; 16C: 100261] 10.1016/j.lrr.2021.100261
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“T-Cell Acute Lymphoblastic Leukemia in a Patient with Pre-existing Essential Thrombocythemia: A Case Report and Literature Review” [Leukemia Research Reports, 2021; 16C: 100264] 10.1016/j.lrr.2021.100264
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“MRD negative CR after azacitidine and venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT.” [Leukemia Research Reports, 2021; 16C: 100267] 10.1016/j.lrr.2021.100267
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Evidence of two different molecular mechanisms as a consequence of an isolated 20q- abnormality in a case of multiple myeloma accompanied with myelodysplastic syndrome” [Leukemia Research Reports, 2021; 16C: 100273] 10.1016/j.lrr.2021.100273
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Total body irradiation-based haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide after administration of inotuzumab ozogamicin: A case report” [Leukemia Research Reports, 2021; 15C: 100241] 10.1016/j.lrr.2021.100241
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report” [Leukemia Research Reports, 2021; 15C: 100243] 10.1016/j.lrr.2021.100243
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Successful treatment of “accelerated” chronic lymphocytic leukemia with single agent ibrutinib: A report of two cases.” [Leukemia Research Reports, 2021; 15C: 100247] 10.1016/j.lrr.2021.100247
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Bilateral massive nephromegaly–A rare presentation of t-cell acute lymphoblastic leukemia” [Leukemia Research Reports, 2021; 15C: 100246] 10.1016/j.lrr.2021.100246
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Myelodysplastic syndrome transforming to atypical chronic myeloid leukemia shows changes in its mutation allele frequency and acquisition of new mutations” [Leukemia Research Reports, 2021; 15C: 100248] 10.1016/j.lrr.2021.100248
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Hyperleukocytosis during clozapine treatment: A rare presentation of B-cell Acute lymphoblastic leukemia” [Leukemia Research Reports, 2021; 15C: 100253] 10.1016/j.lrr.2021.100253
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“A rare case of B cell lymphoblastic leukemia with inv(7)(p15q34) with review of literature.” [Leukemia Research Reports, 2021; 15C: 100250] 10.1016/j.lrr.2021.100250
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Isolated central nervous system relapse of multiple myeloma post autologous stem cell transplant- A rare presentation” [Leukemia Research Reports, 2020; 14C: 100207] 10.1016/j.lrr.2020.100207
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“A case report and case review: Chronic myeloid leukemia (CML) blast phase with myelomastocytic differentiation” [Leukemia Research Reports, 2020; 14C: 100222] 10.1016/j.lrr.2020.100222
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Laryngeal mucous membrane plasmacytosis with 15 year follow-up: Case report and literature review” [Leukemia Research Reports, 2020; 13C: 100190] 10.1016/j.lrr.2019.100190
Informed consent: The authors confirm that written informed consent was obtained from the patient for publication of this case report.
-
•
“Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation” [Leukemia Research Reports, 2019; 12C: 100176] 10.1016/j.lrr.2019.100176
Informed consent: Authors declare that the informed consent is received.